drug-resistant variants

AV5124 Influenza Virus Replication Inhibitor

ChemDiv Helps Advance Viriom’s Influenza Treatment to Successful Phase I Clinical Trials Completion

Staff Reporter December 20, 2023 0

ChemDiv Inc., dedicated to partnering in discovery and development of breakthrough therapies based on its unique chem-bio platforms, announces successful...

Viriom AV5124 Phase I Clinical Trial Results

Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials

Staff Reporter November 21, 2023 0

Viriom Inc., dedicated to advancing a pipeline of highly effective and broadly affordable treatments targeting infectious and malignant diseases globally,...

drug-resistant variants

ChemDiv Helps Advance Viriom’s Influenza Treatment to Successful Phase I Clinical Trials Completion

Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials

Sculpt Clinics Introduces New Laser Hair Removal Technology

HEAL Foundation Announces Healthcare CSR Summit & Awards in New Delhi

Apsara Ice Creams to launch Muskaan initiative on its 53rd anniversary

Milann Fertility Center Celebrates World Breastfeeding Week with ‘Milann’s Embrace’ Initiative

DCN Dx to Showcase New Technologies at NextGen Dx 2024

ChemDiv Helps Advance Viriom’s Influenza Treatment to Successful Phase I Clinical Trials Completion

Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials￼

Interesting Stories For You

Sculpt Clinics Introduces New Laser Hair Removal Technology

HEAL Foundation Announces Healthcare CSR Summit & Awards in New Delhi

Apsara Ice Creams to launch Muskaan initiative on its 53rd anniversary

Milann Fertility Center Celebrates World Breastfeeding Week with ‘Milann’s Embrace’ Initiative

DCN Dx to Showcase New Technologies at NextGen Dx 2024

Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials